Newsletter | July 5, 2023

07.05.23 -- Biology Meets Computer Science For Next-Gen Biologics Drug Discovery

 
Featured Editorial
Industry Insights
Automating Instrument Data Ingestion And Access To Accelerate Lab Productivity

In clinical research, the process of uploading and managing lab data is rife with obstacles. Explore an overview of the major obstacles biotech organizations are facing today.

Utilizing Fed-Batch Intensification To Increase Titer In Biologics Manufacturing

Within Lonza’s facilities, the advanced principles of process intensification have been applied to process and equipment design to increase facility throughput, ultimately offering a wide range of benefits to customers.

Pediatric Dosage Formulation

A biopharmaceutical company known for its successful anti-infective products for adults sought to reformulate the product into an age-appropriate dosage form for young children and pre-teen patients.

Speed To Market – API Large-Scale Commercial Manufacturing

A pharmaceutical company was looking to partner with a CMO with commercial manufacturing capabilities, large-scale assets, multinational sites, and exemplary quality systems/U.S. FDA track record.

Early Development To Clinic – De-Risking A Bioconjugate’s Journey

The journey of a novel bioconjugate into clinic is complex and uncertain. Explore the particular challenges when moving a bioconjugate candidate from early development into clinic.

Most Popular News
Solutions
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.